Insider · CIK 0002022156

Yeleswaram Krishnaswamy

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0002022156

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-25	RAPPRapport Therapeutics, Inc.S Sale	Chief Development Officer	SSale	−20.8K sh	$50.31	−$1.05M	212,063
2026-08-25	RAPPRapport Therapeutics, Inc.S Sale	Chief Development Officer	SSale	−16.2K sh	$51.06	−$827K	195,862
2026-08-24	RAPPRapport Therapeutics, Inc.S Sale	Chief Development Officer	SSale	−13.2K sh	$50.00	−$658K	232,862
2026-08-19	RAPPRapport Therapeutics, Inc.S Sale	Chief Development Officer	SSale	−404 sh	$49.90	−$20.2K	246,022
2026-04-17	RAPPRapport Therapeutics, Inc.S Sale	Chief Development Officer	SSale	−20.2K sh	$39.99	−$809K	246,426
2026-04-14	RAPPRapport Therapeutics, Inc.S Sale	Chief Development Officer	SSale	−10.2K sh	$35.08	−$358K	266,651
2026-04-13	RAPPRapport Therapeutics, Inc.S Sale	Chief Development Officer	SSale	−9,165 sh	$34.97	−$321K	276,851
2026-04-10	RAPPRapport Therapeutics, Inc.S Sale	Chief Development Officer	SSale	−500 sh	$34.98	−$17.5K	286,016
2026-04-08	RAPPRapport Therapeutics, Inc.S Sale	Chief Development Officer	SSale	−360 sh	$34.90	−$12.6K	286,516
2026-03-25	RAPPRapport Therapeutics, Inc.S Sale	Chief Development Officer	SSale	−10.1K sh	$29.99	−$303K	286,876
2026-02-02	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Development Officer	AAward	+120K sh	—	—	120,000
2025-12-31	RAPPRapport Therapeutics, Inc.A Award	Chief Development Officer	AAward	+9,000 sh	—	—	299,831
2025-12-31	RAPPRapport Therapeutics, Inc.S Sale	Chief Development Officer	SSale	−2,840 sh	$30.05	−$85.3K	296,991
2025-02-03	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Development Officer	AAward	+110K sh	—	—	110,000
2024-06-06	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Development Officer	AAward	+84.9K sh	—	—	84,904

Recent filings

Accepted (ET)
Aug 264
Yeleswaram Krishnaswamy0001193125-26-368244
SEC(opens sec.gov)
Aug 204
Yeleswaram Krishnaswamy0001193125-26-359189
SEC(opens sec.gov)
Apr 214
Yeleswaram Krishnaswamy0001193125-26-167091
SEC(opens sec.gov)
Apr 144
Yeleswaram Krishnaswamy0001193125-26-154908
SEC(opens sec.gov)
Apr 94
Yeleswaram Krishnaswamy0001193125-26-149725
SEC(opens sec.gov)
Mar 264
Yeleswaram Krishnaswamy0001193125-26-126410
SEC(opens sec.gov)
Feb 44
Yeleswaram Krishnaswamy0001193125-26-037581
SEC(opens sec.gov)
Jan 54
Yeleswaram Krishnaswamy0001193125-26-002469
SEC(opens sec.gov)
Feb 44
Yeleswaram Krishnaswamy0000950170-25-013753
SEC(opens sec.gov)
Jun 104
Yeleswaram Krishnaswamy0000950170-24-071538
SEC(opens sec.gov)

Companies

Rapport Therapeutics, Inc.Chief Development OfficerRAPP

Address

RAPPORT THERAPEUTICS, INC. 99 HIGH STREET, SUITE 2100

BOSTON, MA, 02110